Results 121 to 130 of about 10,984 (251)

Digital Cutaneous Vascular Responses to Histamine and Neuropeptides in Raynaud's Phenomenon

, 1991
The pathophysiology of Raynaud's phenomenon is not well defined, but active cutaneous microvascular vasoconstriction and emptying must occur to account for the pallor and are reasons for studying the microvasculature.
Christopher B Bunker, Bunker, Christopher B, John C. Foreman, Dowd, Pauline M., Foreman, John C., Pauline M. Dowd   +5 more
core   +1 more source

PO:31:172 | Age and timing of onset of Raynaud's phenomenon and first non-Raynaud sign/symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the systemic sclerosis progression investigation registry of the Italian Society for Rheumatology

Reumatismo
Background. To investigate whether age and timing of Raynaud’s phenomenon (RP) and non-Raynaud’s phenomenon (NRP) onset influence systemic sclerosis (SSc) endotype and prognosis.   Materials and Methods.
Società Italiana di Reumatologia
doaj  

Subjective and objective assessment of enalapril in primary Raynaud's phenomenon

, 1991
1. The efficacy and acceptability of enalapril were assessed in a double‐blind, randomised, placebo controlled cross‐over study in 21 patients with primary Raynaud's phenomenon. 2.
Roath, O.S., DG Waller, Griffin, M.J., RA Hayward, OS Roath, VF Challenor, Waller, D.G., Challenor, V.F., Hayward, R.A., MJ Griffin   +9 more
core   +1 more source

FRI0303 THE EFFECTS OF RIOCIGUAT ON RAYNAUD'S PHENOMENON AND DIGITAL ULCERS IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS: RESULTS FROM THE PHASE IIB RISE-SSC STUDY [PDF]

, 2019
Dinesh Khanna, Yannick Allanore, Christopher P. Denton, Masataka Kuwana, Marco Matucci‐Cerinic, Janet Pope, Janethe de Oliveria Pena, Kaisa Laapas, Zhen Yao, Melanie Hemmrich, Oliver Distler   +10 more
openalex   +1 more source

Drug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance database [PDF]

, 2020
Zaza Putkaradze, Matthieu Roustit, Cracowski Jean‐Luc, Charles Khouri   +3 more
openalex   +1 more source

Assessment and management of Raynaud's phenomenon

, 2017
Raynaud's phenomenon (RP) is commonly encountered in primary care and can either be a primary condition or occur secondary to a wide range of underlying medical conditions and drug therapies.
Michael Hughes, Ariane L Herrick, Hughes, Michael; id_orcid, Herrick, Ariane L   +3 more
core   +1 more source

Subclinical manifestations of autoimmune rheumatic diseases in primary Raynaud's phenomenon

, 1985
Twenty-nine patients with primary Raynaud's phenomenon underwent functional (pulmonary functional studies and oesophageal manometry), histologic (minor salivary gland biopsy) and serologic (autoantibodies) evaluation for subclinical manifestations of ...
Tsianos, E. B., Constantopoulos, S. H., Dalavanga, Y. A., Tzioufas, A. G., Moutsopoulos, H. M., Papadimitriou, C.   +5 more
core  

Immunological studies in raynaud's phenomenon [PDF]

, 1979
The clinical significance of Raynaud's phenomenon (RP), an intermittent vasospasm of the digital arteries on exposure to cold, has a considerable variability. It may be a harmless, isolated vascular spasm, more or less hindering the patient's daily life,
Meulen, Jan van der,, Meulen, Jan van der   +1 more
core  

Infrared thermography in diagnosis of Raynaud's phenomenon - 2nd part [PDF]

, 2018
Jan Šternberský, Jana Zapletalová
openalex   +1 more source

Exacerbation of Raynaud's phenomenon induced by Fremanezumab in meridional Brazil: A case report

Cephalalgia Reports
Background As calcitonin gene-related peptide (CGRP)-pathway-blocking therapies become more widely used, infrequent adverse events related to impaired compensatory peripheral vasodilation or to microvasculature regulation, such as Raynaud's phenomenon ...
Fernando Kowacs
doaj   +1 more source